EXACT Therapeutics
Lucy Wabakken is a seasoned professional in regulatory affairs and quality assurance with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the VP of Regulatory and QA at EXACT Therapeutics since November 2022, Lucy previously held the position of Regulatory Affairs Director at PCI Biotech from May 2012 to November 2022. Prior to that, Lucy was the Director of International Regulatory Affairs at Nycomed from August 1999 to April 2012. Lucy Wabakken earned a Cand. pharm. degree from the University of Oslo.
This person is not in any teams
This person is not in any offices
EXACT Therapeutics
1 followers
EXACT Therapeutics is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT®sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.